Reduced expression of foxpl as a contributing factor in huntington’s disease

Anto Sam Crosslee Louis Sam Titus, Tanzeen Yusuff, Marléne Cassar, Elizabeth Thomas, Doris Kretzschmar, Santosh R. D’Mello

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Huntington’s disease (HD) is an inherited neurodegenerative disease caused by a polyglutamine expansion in the huntington protein (htt). The neuropathological hallmark of HDis the loss of neurons in the striatum and, to a lesser extent, in the cortex. Foxp1 is a member of the Forkhead family of transcription factors expressed selectively in the striatum and the cortex. In the brain, three major Foxp1 isoforms are expressed: isoform-A (~90 kDa), isoform-D (~70 kDa), and isoform-C (~50 kDa). We find that expression of Foxp1 isoform-A and -D is selectively reduced in the striatum and cortex of R6/2HDmice as well as in the striatum ofHDpatients. Furthermore, expression of mutant htt in neurons results in the downregulation of Foxp1. Elevating expression of isoform-A or -D protects cortical neurons from death caused by the expression of mutant htt. On the other hand, knockdown of Foxp1 promotes death in otherwise healthy neurons. Neuroprotection by Foxp1 is likely to be mediated by the transcriptional stimulation of the cell-cycle inhibitory protein p21Waf1/Cip1. Consistently, Foxp1 activates transcription of the p21Waf1/Cip1 gene promoter, and over expression of Foxp1 in neurons results in the elevation of p21 expression. Moreover, knockingdownof p21Waf1/Cip1 blocks the ability of Foxp1 to protect neurons from mut-Htt-induced neurotoxicity. We propose that the selective vulnerability of neurons of the striatum and cortex in HD is related to the loss of expression of Foxp1, a protein that is highly expressed in these neurons and required for their survival.

Original languageEnglish (US)
Pages (from-to)6575-6587
Number of pages13
JournalJournal of Neuroscience
Volume37
Issue number27
DOIs
StatePublished - 2017

Fingerprint

Huntington Disease
Neurons
Protein Isoforms
Mutant Proteins
Forkhead Transcription Factors
Cell Cycle Proteins
Aptitude
Neurodegenerative Diseases
Proteins
Down-Regulation
Brain
Genes

Keywords

  • Foxp1
  • Huntington’s disease
  • Neurodegeneration
  • Neuroprotection

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Reduced expression of foxpl as a contributing factor in huntington’s disease. / Titus, Anto Sam Crosslee Louis Sam; Yusuff, Tanzeen; Cassar, Marléne; Thomas, Elizabeth; Kretzschmar, Doris; D’Mello, Santosh R.

In: Journal of Neuroscience, Vol. 37, No. 27, 2017, p. 6575-6587.

Research output: Contribution to journalArticle

Titus, Anto Sam Crosslee Louis Sam ; Yusuff, Tanzeen ; Cassar, Marléne ; Thomas, Elizabeth ; Kretzschmar, Doris ; D’Mello, Santosh R. / Reduced expression of foxpl as a contributing factor in huntington’s disease. In: Journal of Neuroscience. 2017 ; Vol. 37, No. 27. pp. 6575-6587.
@article{ed6a248441464e4ba19ffe97bfe419c9,
title = "Reduced expression of foxpl as a contributing factor in huntington’s disease",
abstract = "Huntington’s disease (HD) is an inherited neurodegenerative disease caused by a polyglutamine expansion in the huntington protein (htt). The neuropathological hallmark of HDis the loss of neurons in the striatum and, to a lesser extent, in the cortex. Foxp1 is a member of the Forkhead family of transcription factors expressed selectively in the striatum and the cortex. In the brain, three major Foxp1 isoforms are expressed: isoform-A (~90 kDa), isoform-D (~70 kDa), and isoform-C (~50 kDa). We find that expression of Foxp1 isoform-A and -D is selectively reduced in the striatum and cortex of R6/2HDmice as well as in the striatum ofHDpatients. Furthermore, expression of mutant htt in neurons results in the downregulation of Foxp1. Elevating expression of isoform-A or -D protects cortical neurons from death caused by the expression of mutant htt. On the other hand, knockdown of Foxp1 promotes death in otherwise healthy neurons. Neuroprotection by Foxp1 is likely to be mediated by the transcriptional stimulation of the cell-cycle inhibitory protein p21Waf1/Cip1. Consistently, Foxp1 activates transcription of the p21Waf1/Cip1 gene promoter, and over expression of Foxp1 in neurons results in the elevation of p21 expression. Moreover, knockingdownof p21Waf1/Cip1 blocks the ability of Foxp1 to protect neurons from mut-Htt-induced neurotoxicity. We propose that the selective vulnerability of neurons of the striatum and cortex in HD is related to the loss of expression of Foxp1, a protein that is highly expressed in these neurons and required for their survival.",
keywords = "Foxp1, Huntington’s disease, Neurodegeneration, Neuroprotection",
author = "Titus, {Anto Sam Crosslee Louis Sam} and Tanzeen Yusuff and Marl{\'e}ne Cassar and Elizabeth Thomas and Doris Kretzschmar and D’Mello, {Santosh R.}",
year = "2017",
doi = "10.1523/JNEUROSCI.3612-16.2017",
language = "English (US)",
volume = "37",
pages = "6575--6587",
journal = "Journal of Neuroscience",
issn = "0270-6474",
publisher = "Society for Neuroscience",
number = "27",

}

TY - JOUR

T1 - Reduced expression of foxpl as a contributing factor in huntington’s disease

AU - Titus, Anto Sam Crosslee Louis Sam

AU - Yusuff, Tanzeen

AU - Cassar, Marléne

AU - Thomas, Elizabeth

AU - Kretzschmar, Doris

AU - D’Mello, Santosh R.

PY - 2017

Y1 - 2017

N2 - Huntington’s disease (HD) is an inherited neurodegenerative disease caused by a polyglutamine expansion in the huntington protein (htt). The neuropathological hallmark of HDis the loss of neurons in the striatum and, to a lesser extent, in the cortex. Foxp1 is a member of the Forkhead family of transcription factors expressed selectively in the striatum and the cortex. In the brain, three major Foxp1 isoforms are expressed: isoform-A (~90 kDa), isoform-D (~70 kDa), and isoform-C (~50 kDa). We find that expression of Foxp1 isoform-A and -D is selectively reduced in the striatum and cortex of R6/2HDmice as well as in the striatum ofHDpatients. Furthermore, expression of mutant htt in neurons results in the downregulation of Foxp1. Elevating expression of isoform-A or -D protects cortical neurons from death caused by the expression of mutant htt. On the other hand, knockdown of Foxp1 promotes death in otherwise healthy neurons. Neuroprotection by Foxp1 is likely to be mediated by the transcriptional stimulation of the cell-cycle inhibitory protein p21Waf1/Cip1. Consistently, Foxp1 activates transcription of the p21Waf1/Cip1 gene promoter, and over expression of Foxp1 in neurons results in the elevation of p21 expression. Moreover, knockingdownof p21Waf1/Cip1 blocks the ability of Foxp1 to protect neurons from mut-Htt-induced neurotoxicity. We propose that the selective vulnerability of neurons of the striatum and cortex in HD is related to the loss of expression of Foxp1, a protein that is highly expressed in these neurons and required for their survival.

AB - Huntington’s disease (HD) is an inherited neurodegenerative disease caused by a polyglutamine expansion in the huntington protein (htt). The neuropathological hallmark of HDis the loss of neurons in the striatum and, to a lesser extent, in the cortex. Foxp1 is a member of the Forkhead family of transcription factors expressed selectively in the striatum and the cortex. In the brain, three major Foxp1 isoforms are expressed: isoform-A (~90 kDa), isoform-D (~70 kDa), and isoform-C (~50 kDa). We find that expression of Foxp1 isoform-A and -D is selectively reduced in the striatum and cortex of R6/2HDmice as well as in the striatum ofHDpatients. Furthermore, expression of mutant htt in neurons results in the downregulation of Foxp1. Elevating expression of isoform-A or -D protects cortical neurons from death caused by the expression of mutant htt. On the other hand, knockdown of Foxp1 promotes death in otherwise healthy neurons. Neuroprotection by Foxp1 is likely to be mediated by the transcriptional stimulation of the cell-cycle inhibitory protein p21Waf1/Cip1. Consistently, Foxp1 activates transcription of the p21Waf1/Cip1 gene promoter, and over expression of Foxp1 in neurons results in the elevation of p21 expression. Moreover, knockingdownof p21Waf1/Cip1 blocks the ability of Foxp1 to protect neurons from mut-Htt-induced neurotoxicity. We propose that the selective vulnerability of neurons of the striatum and cortex in HD is related to the loss of expression of Foxp1, a protein that is highly expressed in these neurons and required for their survival.

KW - Foxp1

KW - Huntington’s disease

KW - Neurodegeneration

KW - Neuroprotection

UR - http://www.scopus.com/inward/record.url?scp=85022067434&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85022067434&partnerID=8YFLogxK

U2 - 10.1523/JNEUROSCI.3612-16.2017

DO - 10.1523/JNEUROSCI.3612-16.2017

M3 - Article

C2 - 28550168

AN - SCOPUS:85022067434

VL - 37

SP - 6575

EP - 6587

JO - Journal of Neuroscience

JF - Journal of Neuroscience

SN - 0270-6474

IS - 27

ER -